Form 4: Pfizer Executive Rady A. Johnson Reports Acquisition of Phantom Stock Units

Executive Vice President Rady A. Johnson reports acquiring phantom stock units in Pfizer through the Supplemental Savings Plan.

Summary

• Rady A. Johnson, an Executive Vice President at Pfizer Inc., filed a Form 4 on September 3, 2024, reporting a transaction on August 30, 2024.
• The transaction involved the acquisition of 6 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the phantom stock units was $29.01.
• Following the reported transaction, Johnson directly owns 9,140 derivative securities.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, and the sentiment is neutral. It reflects a routine transaction related to executive compensation.

Positives

• The acquisition of phantom stock units through the Supplemental Savings Plan aligns the executive's interests with the company's performance.
• The ability to transfer the units into an alternative investment account provides flexibility for the executive.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates an executive's participation in a company savings plan, which is a common practice.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves phantom stock units acquired through a savings plan.

Key Dates